Praxis Precision Medicines Quarterly Cash Flow Statement
NASDAQ: PRAXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
257.00-2.86 (-1.10%)
Market open · Delayed 15 min · as of Oct 12, 9:59 AM ET
Praxis Precision Medicines free cash flow
In the quarter ended Jun 30, 2026, Praxis Precision Medicines generated -$77.5 million of operating cash flow and spent $245,000 on capital expenditures. That left free cash flow of -$77.8 million.
Summary generated from market data by MetaCap's automated system. Methodology
Praxis Precision Medicines cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -83.72M | -92.56M | -88.91M | -73.93M | -71.13M | -69.30M | -58.68M | -51.91M | -32.68M | -39.55M | -26.88M | -24.63M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 33.00K | 39.00K | 28.00K | 19.00K | 46.00K | 47.00K | 47.00K | 92.00K | 107.00K | 112.00K | 111.00K | 109.00K |
| Stock-Based Compensation | 11.31M | 17.11M | 9.94M | 7.45M | 7.77M | 8.79M | 8.57M | 12.43M | 5.88M | 14.47M | 5.73M | 5.76M |
| Change in Working Capital | -3.80M | -10.18M | 3.34M | 2.18M | 9.68M | 8.74M | -4.63M | 13.94M | 994.00K | 1.74M | -2.78M | -4.41M |
| Operating Cash Flow | -77.54M | -86.15M | -76.33M | -65.06M | -54.68M | -53.01M | -56.12M | -27.50M | -27.28M | -20.86M | -23.86M | -23.21M |
| Capital Expenditures | -245.00K | -62.00K | 0 | 0 | -56.00K | 0 | 0 | 0 | — | — | -50.00K | 0 |
| Investing Cash Flow | 10.98M | -344.27M | -328.39M | 50.41M | 17.89M | -51.06M | -10.92M | 49.57M | -195.92M | -91.22M | -50.00K | 0 |
| Financing Cash Flow | 4.57M | 609.43M | 612.52M | 6.76M | 28.63M | 54.27M | 113.77M | 1.44M | 216.36M | 182.76M | 4.13M | 0 |
| Net Change in Cash | -61.99M | 179.00M | 207.80M | -7.89M | -8.15M | -49.80M | 46.73M | 23.50M | -6.84M | 70.68M | -19.79M | -23.21M |
| Free Cash Flow | -77.79M | -86.21M | -76.33M | -65.06M | -54.73M | -53.01M | -56.12M | -27.50M | -27.28M | -20.86M | -23.91M | -23.21M |
This table shows 12 quarterly periods of Praxis Precision Medicines's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PRAX's reporting calendar. What is a cash flow statement?